Understanding the structural basis of linezolid resistance at the ribosomal binding site aids in developing next-generation oxazolidinones.
No takes yet. Share an insight, caveat, or question.
Linezolid use warrants resistance surveillance for ribosomal modifications; leaves open structure-based design of next-generation oxazolidinones.
Long et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: